The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
Open accessAbstract
Glioblastoma multiforme (GBM), the most common and lethal tumor of the adult brain, generally shows chemo- and radioresistance. MicroRNAs (miRs) regulate physiological processes, such as resistance of GBM cells to temozolomide (TMZ). Although miRs are attractive targets for cancer therapeutics, the effectiveness of this approach requires targeted delivery. Mesenchymal stem cells (MSCs) can migrate to the sites of cancers, including GBM. We report on an increase in miR-9 in TMZ-resistant GBM cells. miR-9 was involved in the expression of the drug efflux transporter, P-glycoprotein. To block miR-9, methods were developed with Cy5-tagged anti-miR-9. Dye-transfer studies indicated intracellular communication between GBM cells and MSCs. This occurred by gap junctional intercellular communication and the release of microvesicles. In both cases, anti-miR-9 was transferred from MSCs to GBM cells. However, the major form of transfer occurred with the microvesicles. The delivery of anti-miR-9 to the resistant GBM cells reversed the expression of the multidrug transporter and sensitized the GBM cells to TMZ, as shown by increased cell death and caspase activity. The data showed a potential role for MSCs in the functional delivery of synthetic anti-miR-9 to reverse the chemoresistance of GBM cells.Molecular Therapy-Nucleic Acids (2013) 2, e126; doi:10.1038/mtna.2013.60; published online 1 October 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringnér, M., Mörgelin, M., Bourseau-Guilmain, E., Bengzon, J., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220998110 · Cited by 939
Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S., & Rameshwar, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3426 · Cited by 432
Self-citationLim, P. K., Bliss, S. A., Patel, S. A., Taborga, M., Dave, M. A., Gregory, L. A., Greco, S. J., Bryan, M., Patel, P. S., & Rameshwar, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2372 · Cited by 416
Self-citationTherapeutic potential of mesenchymal stem cell-derived microvesicles
Biancone, L., Bruno, S., Deregibus, M. C., Tetta, C., & Camussi, G. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs168 · Cited by 393
Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., Phillips, M., & Herrmann, R. P. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.021 · Cited by 333
Bao, L., Hazari, S., Mehra, S., Kaushal, D., Moroz, K., & Dash, S. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.024 · Cited by 275
Mao, H., LeBrun, D. G., Yang, J., Zhu, V. F., & Li, M. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.630050 · Cited by 266
Juszczak, G. R., & Swiergiel, A. H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.014 · Cited by 211
A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs
Kim, T.-M., Huang, W., Park, R., Park, P. J., & Johnson, M. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4117 · Cited by 193
MicroRNAs: regulators of neuronal fate
Sun, A. X., Crabtree, G. R., & Yoo, A. S. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.12.007 · Cited by 176
HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells
Matuskova, M., Hlubinova, K., Pastorakova, A., Hunakova, L., Altanerova, V., Altaner, C., & Kucerova, L. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.08.028 · Cited by 171
Oliva, C. R., Moellering, D. R., Gillespie, G. Y., & Griguer, C. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024665 · Cited by 163
Pendleton, C. A., Li, Q., Chesler, D. A., Yuan, K., Guerrero‐Cazares, H., & Quiñones‐Hinojosa, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058198 · Cited by 141
Schaich, M. A., Kestel, L., Pfirrmann, M., Robel, K., Illmer, T., Krämer, M., Dill, C., Ehninger, G., Schackert, G., & Krex, D. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn548 · Cited by 133
Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
Cogolludo, A. L., Moreno, L., Frazziano, G., Moral‐Sanz, J., Menendez, C., Castaneda, J., González, C., Villamor, E., & Pérez‐Vizcaíno, F. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn349 · Cited by 115
Chou, C.-W., Wang, C.-C., Wu, C., Lin, Y., Lee, Y.-C., Cheng, Y.-W., & Hsieh, C. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos195 · Cited by 111
Stem cell-based therapy for malignant glioma
Bexell, D., Svensson, A., & Bengzon, J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.006 · Cited by 88
Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells
John-Aryankalayil, M., Palayoor, S. T., Makinde, A. Y., Cerna, D., Simone, C. B., Falduto, M. T., Magnuson, S. R., & Coleman, C. N. (2012) · Radiation Research · doi:10.1667/rr2703.1 · Cited by 75
Mesenchymal Stem Cells in drug/gene Delivery: Implications for Cell Therapy
Greco, S. J., & Rameshwar, P. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.69 · Cited by 69
Self-citationMicroRNA Implications across Neurodevelopment and Neuropathology
Martino, S., di Girolamo, I., Orlacchio, A., Datti, A., & Orlacchio, A. (2009) · BioMed Research International · doi:10.1155/2009/654346 · Cited by 68
Biology and applications of Mesenchymal Stem Cells
Chagastelles, P. C., Nardi, N. B., & Camassola, M. (2010) · Science Progress · doi:10.3184/003685010x12708175591515 · Cited by 40
MicroRNA targeting as a therapeutic strategy against glioma.
Auffinger, B., Thaci, B., Ahmed, A. U., Ulasov, I., & Lesniak, M. (2013) · Current molecular medicine · doi:10.2174/1566524011313040006 · Cited by 37
Glioma Stem Cells: Their Role in Chemoresistance
Yamada, R., & Nakano, I. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.01.004 · Cited by 29
Cited by
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.44 · Cited by 1,227
Temozolomide resistance in glioblastoma multiforme
Lee, S. Y. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.04.007 · Cited by 1,163
Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.04.005 · Cited by 704
Metadata
- Authors
- Munoz, J. L., Bliss, S. A., Greco, S. J., Ramkissoon, S. H., Ligon, K. L., & Rameshwar, P.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2013
- Volume
- 2
- Pages
- e126
- ISSN
- 2162-2531 (ISSN-L)
- OpenAlex
- W2135830946
- Cited by
- 520
- References
- 24
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.